These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32062148)

  • 61. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer's Mouse Model.
    He P; Xin W; Schulz P; Sierks MR
    Mol Neurobiol; 2019 Nov; 56(11):7420-7432. PubMed ID: 31041656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
    Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
    J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
    Wang CY; Wang ZY; Xie JW; Wang T; Wang X; Xu Y; Cai JH
    Neurobiol Aging; 2016 Feb; 38():32-46. PubMed ID: 26827641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
    Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
    Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer's Disease.
    Qian K; Bao X; Li Y; Wang P; Guo Q; Yang P; Xu S; Yu F; Meng R; Cheng Y; Sheng D; Cao J; Xu M; Wu J; Wang T; Wang Y; Xie Q; Lu W; Zhang Q
    ACS Nano; 2022 Jul; 16(7):11455-11472. PubMed ID: 35839463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects against Aβ-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model.
    Park YH; Shin SJ; Kim HS; Hong SB; Kim S; Nam Y; Kim JJ; Lim K; Kim JS; Kim JI; Jeon SG; Moon M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy.
    Zheng J; Akbari M; Schirmer C; Reynaert ML; Loyens A; Lefebvre B; Buée L; Croteau DL; Galas MC; Bohr VA
    Acta Neuropathol Commun; 2020 Mar; 8(1):25. PubMed ID: 32131898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease.
    Brose RD; Lehrmann E; Zhang Y; Reeves RH; Smith KD; Mattson MP
    Neurobiol Aging; 2018 Dec; 72():121-133. PubMed ID: 30245242
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer's disease.
    Oka S; Leon J; Sakumi K; Ide T; Kang D; LaFerla FM; Nakabeppu Y
    Sci Rep; 2016 Nov; 6():37889. PubMed ID: 27897204
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice.
    Han Y; Gao C; Wang H; Sun J; Liang M; Feng Y; Liu Q; Fu S; Cui L; Gao C; Li Y; Yang Y; Sun B
    Bioact Mater; 2021 Feb; 6(2):529-542. PubMed ID: 32995678
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Ashleigh T; Swerdlow RH; Beal MF
    Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease.
    Awasthi S; Hindle A; Sawant NA; George M; Vijayan M; Kshirsagar S; Morton H; Bunquin LE; Palade PT; Lawrence JJ; Khan H; Bose C; Reddy PH; Singh SP
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Reiss AB; Ahmed S; Dayaramani C; Glass AD; Gomolin IH; Pinkhasov A; Stecker MM; Wisniewski T; De Leon J
    Exp Gerontol; 2022 Jul; 164():111828. PubMed ID: 35508280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exposure of combination of environmental pollutant, lead (Pb) and β-amyloid peptides causes mitochondrial dysfunction and oxidative stress in human neuronal cells.
    Bandaru LJM; Murumulla L; C BL; D KP; Challa S
    J Bioenerg Biomembr; 2023 Feb; 55(1):79-89. PubMed ID: 36637735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A stepwise-targeting strategy for the treatment of cerebral ischemic stroke.
    Hu J; Tan X; Wang D; Li Y; Liang H; Peng J; Li F; Zhou Q; Geng P; Wang S; Yu Y; Liu J
    J Nanobiotechnology; 2021 Nov; 19(1):371. PubMed ID: 34789285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of UCP4 in astrocytic mitochondria prevents multilevel dysfunctions in a mouse model of Alzheimer's disease.
    Rosenberg N; Reva M; Binda F; Restivo L; Depierre P; Puyal J; Briquet M; Bernardinelli Y; Rocher AB; Markram H; Chatton JY
    Glia; 2023 Apr; 71(4):957-973. PubMed ID: 36537556
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.
    Dumont M; Lin MT; Beal MF
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S633-43. PubMed ID: 20421689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.